Get unlimited access. Save 70% when you subscribe today.

SmartCompany
Icon

Search

Create a free account, or log in

Business Advice

Long-serving Pharmaxis chief Alan Robertson steps down, making way for COO

Gary Phillips yesterday replaced founder Alan Robertson as CEO of Australian biotech company Pharmaxis yesterday. Phillips, who has been the company’s COO for five years, has stepped right into the frying pan: on Monday the company is due to respond to the American Federal Drug Administration, which dealt it a huge blow last month by […]
Myriam Robin
Myriam Robin
Icon

Share

Gary Phillips yesterday replaced founder Alan Robertson as CEO of Australian biotech company Pharmaxis yesterday.

Phillips, who has been the company’s COO for five years, has stepped right into the frying pan: on Monday the company is due to respond to the American Federal Drug Administration, which dealt it a huge blow last month by recommending against approving the company’s drug, Bronchitol, which treats cystic fibrosis.

Phillips holds an MBA as well as a degree in pharmacy, and was previously a CEO of Novartis. Robertson is staying on with Pharmaxis as a consultant for a year. 

About the author

Myriam Robin

Myriam Robin is a reporter for SmartCompany and its sister site LeadingCompany. She has degrees in economics, international studies and journalism. She likes writing about businesses taking risks and doing new things.

Recommended for you